Loading chat...
LA HB423
Bill
Status
6/20/2025
Primary Sponsor
Jeremy LaCombe
Click for details
AI Summary
-
Insurers are prohibited from substituting immediate or extended release medications lacking abuse deterrent properties when a licensed physician prescribes an opioid with defined abuse deterrent properties for pain treatment
-
Violations of advertising requirements using "Doctor" or "Dr." are now enforceable under the Unfair Trade Practices and Consumer Protection Law
-
Professional licensing boards may also enforce violations through their own promulgated rules and penalties
-
Makes technical correction by removing "chronic" from the prescription medication section title, broadening application to general pain prescriptions
Legislative Description
Provides relative to healthcare providers displaying evidence of proper licensure in advertising (EN NO IMPACT See Note)
HEALTH CARE/PROVIDERS
Last Action
Effective date: 08/01/2025.
6/20/2025